Functional validation of MB-OFDM system using HW-in the loop

Functional validation of complex digital systems is a hard and critical task in the design flow. In particular, when dealing with communication systems, like Multiband Orthogonal Frequency Division Multiplexing Ultra Wideband (MB-OFDM UWB), the design decisions taken during the process have to be validated at different levels in an easy way. In this work, a unified algorithm-architecture-circuit co-design environment for this type of systems, to be implemented in FPGA, is presented. The main objective is to find an efficient methodology for designing a configurable optimized MB-OFDM UWB system by using as few efforts as possible in verification stage, so as to speed up the development period. Although this efficient design methodology is tested and considered to be suitable for almost all types of complex FPGA designs, we propose a solution where both the circuit and the communication channel are tested at different levels (algorithmic, RTL, hardware device) using a common testbench.

A hardware in the loop design methodology for FPGA system and its application to complex functions

In this work, a unified algorithm-architecture-circuit co-design environment for complex FPGA system development is presented. The main objective is to find an efficient methodology for designing a configurable optimized FPGA system by using as few efforts as possible in verification stage, so as to speed up the development period. A proposed high performance FFT/iFFT processor for Multiband Orthogonal Frequency Division Multiplexing Ultra Wideband (MB-OFDM UWB) system design process is given as an example to demonstrate the proposed methodology. This efficient design methodology is tested and considered to be suitable for almost all types of complex FPGA system designs and verifications.

EPIC (Entorno de Páncreas Artificial con Interfaz Clínica)

La Diabetes Mellitus se define como el trastorno del metabolismo de los carbohidratos, resultante de una producción insuficiente o nula de insulina en las células beta del páncreas, o la manifestación de una sensibilidad reducida a la insulina por parte del sistema metabólico. La diabetes tipo 1 se caracteriza por la nula producción de insulina por la destrucción de las células beta del páncreas. Si no hay insulina en el torrente sanguíneo, la glucosa no puede ser absorbida por las células, produciéndose un estado de hiperglucemia en el paciente, que a medio y largo plazo si no es tratado puede ocasionar severas enfermedades, conocidos como síndromes de la diabetes. La diabetes tipo 1 es una enfermedad incurable pero controlable. La terapia para esta enfermedad consiste en la aplicación exógena de insulina con el objetivo de mantener el nivel de glucosa en sangre dentro de los límites normales. Dentro de las múltiples formas de aplicación de la insulina, en este proyecto se usará una bomba de infusión, que unida a un sensor subcutáneo de glucosa permitirá crear un lazo de control autónomo que regule la cantidad optima de insulina aplicada en cada momento. Cuando el algoritmo de control se utiliza en un sistema digital, junto con el sensor subcutáneo y bomba de infusión subcutánea, se conoce como páncreas artificial endocrino (PAE) de uso ambulatorio, hoy día todavía en fase de investigación. Estos algoritmos de control metabólico deben de ser evaluados en simulación para asegurar la integridad física de los pacientes, por lo que es necesario diseñar un sistema de simulación mediante el cual asegure la fiabilidad del PAE. Este sistema de simulación conecta los algoritmos con modelos metabólicos matemáticos para obtener una visión previa de su funcionamiento. En este escenario se diseñó DIABSIM, una herramienta desarrollada en LabViewTM, que posteriormente se trasladó a MATLABTM, y basada en el modelo matemático compartimental propuesto por Hovorka, con la que poder simular y evaluar distintos tipos de terapias y reguladores en lazo cerrado. Para comprobar que estas terapias y reguladores funcionan, una vez simulados y evaluados, se tiene que pasar a la experimentación real a través de un protocolo de ensayo clínico real, como paso previo al PEA ambulatorio. Para poder gestionar este protocolo de ensayo clínico real para la verificación de los algoritmos de control, se creó una interfaz de usuario a través de una serie de funciones de simulación y evaluación de terapias con insulina realizadas con MATLABTM (GUI: Graphics User Interface), conocido como Entorno de Páncreas artificial con Interfaz Clínica (EPIC). EPIC ha sido ya utilizada en 10 ensayos clínicos de los que se han ido proponiendo posibles mejoras, ampliaciones y/o cambios. Este proyecto propone una versión mejorada de la interfaz de usuario EPIC propuesta en un proyecto anterior para gestionar un protocolo de ensayo clínico real para la verificación de algoritmos de control en un ambiente hospitalario muy controlado, además de estudiar la viabilidad de conectar el GUI con SimulinkTM (entorno gráfico de Matlab de simulación de sistemas) para su conexión con un nuevo simulador de pacientes aprobado por la JDRF (Juvenil Diabetes Research Foundation). SUMMARY The diabetes mellitus is a metabolic disorder of carbohydrates, as result of an insufficient or null production of insulin in the beta cellules of pancreas, or the manifestation of a reduced sensibility to the insulin from the metabolic system. The type 1 diabetes is characterized for a null production of insulin due to destruction of the beta cellules. Without insulin in the bloodstream, glucose can’t be absorbed by the cellules, producing a hyperglycemia state in the patient and if pass a medium or long time and is not treated can cause severe disease like diabetes syndrome. The type 1 diabetes is an incurable disease but controllable one. The therapy for this disease consists on the exogenous insulin administration with the objective to maintain the glucose level in blood within the normal limits. For the insulin administration, in this project is used an infusion pump, that permit with a subcutaneous glucose sensor, create an autonomous control loop that regulate the optimal insulin amount apply in each moment. When the control algorithm is used in a digital system, with the subcutaneous senor and infusion subcutaneous pump, is named as “Artificial Endocrine Pancreas” for ambulatory use, currently under investigate. These metabolic control algorithms should be evaluates in simulation for assure patients’ physical integrity, for this reason is necessary to design a simulation system that assure the reliability of PAE. This simulation system connects algorithms with metabolic mathematics models for get a previous vision of its performance. In this scenario was created DIABSIMTM, a tool developed in LabView, that later was converted to MATLABTM, and based in the compartmental mathematic model proposed by Hovorka that could simulate and evaluate several different types of therapy and regulators in closed loop. To check the performance of these therapies and regulators, when have been simulated and evaluated, will be necessary to pass to real experimentation through a protocol of real clinical test like previous step to ambulatory PEA. To manage this protocol was created an user interface through the simulation and evaluation functions od therapies with insulin realized with MATLABTM (GUI: Graphics User Interface), known as “Entorno de Páncreas artificial con Interfaz Clínica” (EPIC).EPIC have been used in 10 clinical tests which have been proposed improvements, adds and changes. This project proposes a best version of user interface EPIC proposed in another project for manage a real test clinical protocol for checking control algorithms in a controlled hospital environment and besides studying viability to connect the GUI with SimulinkTM (Matlab graphical environment in systems simulation) for its connection with a new patients simulator approved for the JDRF (Juvenil Diabetes Research Foundation).

Personalized rule-based closed-loop control algorithm for type 1 diabetes

Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancreas (CGM sensor, insulin pump and control algorithm) is promising to outperform current open-loop therapies.

Effects of extracellular Ca2+ concentration on hair-bundle stiffness and gating-spring integrity in hair cells

When a hair cell is stimulated by positive deflection of its hair bundle, increased tension in gating springs opens transduction channels, permitting cations to enter stereocilia and depolarize the cell. Ca2+ is thought to be required in mechanoelectrical transduction, for exposure of hair bundles to Ca2+ chelators eliminates responsiveness by disrupting tip links, filamentous interstereociliary connections that probably are the gating springs. Ca2+ also participates in adaptation to stimuli by controlling the activity of a molecular motor that sets gating-spring tension. Using a flexible glass fiber to measure hair-bundle stiffness, we investigated the effect of Ca2+ concentration on stiffness before and after the disruption of gating springs. The stiffness of intact hair bundles depended nonmonotonically on the extracellular Ca2+ concentration; the maximal stiffness of ≈1200 μN⋅m−1 occurred when bundles were bathed in solutions containing 250 μM Ca2+, approximately the concentration found in frog endolymph. For cells exposed to solutions with sufficient chelator capacity to reduce the Ca2+ concentration below ≈100 nM, hair-bundle stiffness fell to ≈200 μN⋅m−1 and no longer exhibited Ca2+-dependent changes. Because cells so treated lost mechanoelectrical transduction, we attribute the reduction in bundle stiffness to tip-link disruption. The results indicate that gating springs are not linearly elastic; instead, they stiffen with increased strain, which rises with adaptation-motor activity at the physiological extracellular Ca2+ concentration.

The pressures produced by the striking of momentary arcs in closed vessels

Mode of access: Internet.

In-pile loop test for the pebble bed reactor fuel development program : final report /

"Final report to Sanderson and Porter for subcontract no. S-3 under USAEC Prime Contract no. AT(30-1)-2378."

Peter Anthony Dey; integrity in public service,

"Notes and references": p. [215]-235.

Analysis of cargo tank integrity in rollovers : final report /

"FHWA contract: DOT-FH-9193."

Operator's manual : lathe, engine, floor mounted, sliding bed gap, 17 to 28 in. rated swing, 50 in. open and 30 in. closed between centers ... (LeBlond Machine Tool Company model 17" Regal), (3416-828-3714).

Includes indexes.

Motor unit synchronization of the vasti muscles in closed and open chain tasks

Objectives: To investigate motor unit synchronization between medial and lateral vasti and whether such synchronization differs in closed and open chain tasks. Design: Electromyographic recordings of single motor unit action potentials were made from the vastus medialis obliquus (VMO) and multiunit recordings from vastus lateralis during isometric contractions at 30 degrees of knee flexion in closed and open chain conditions. Setting: Laboratory. Participants: Five volunteers with no history of knee pain (age, 30 +/- 3.32y). Interventions: Not applicable. Main Outcome Measure: The degree of synchronization between motor unit firing was evaluated by identifying peaks in the electromyographic averages of the vastus lateralis, triggered from motor unit action potentials in the VMO, and the proportion of power in the power spectral density of the triggered average at the firing frequency of the reference motor unit. The proportion of cases in which there was significant power and peaks in the triggered averages was calculated. Results: The proportion of trials with peaks in the triggered averages of the vastus lateralis electromyographic activity was greater than 61.5% in all tasks, and there was a significantly greater proportion of cases where power in the spectrum was greater than 7.5% (P = .01) for the closed chain condition. Conclusions: There was a high proportion of synchronized motor units between the 2 muscles during isometric contractions, with evidence for greater common drive between the VMO and vastus lateralis in closed chain tasks. This has implications for rehabilitation because it suggests that closed chain tasks may generate better coordination between the vasti muscles.

Multiple roles of charged amino acids in cytoplasmic loop 7 for expression and function of the multidrug and organic anion transporter MRP1 (ABCC1)

Multidrug resistance protein MRP1 mediates the ATP-dependent efflux of many chemotherapeutic agents and organic anions. MRP1 has two nucleotide binding sites (NBSs) and three membrane spanning domains (MSDs) containing 17 transmembrane helices linked by extracellular and cytoplasmic loops (CL). Homology models suggest that CL7 (amino acids 1141-1195) is in a position where it could participate in signaling between the MSDs and NBSs during the transport process. We have individually replaced eight charged residues in CL7 with Ala, and in some cases, an amino acid with the same charge, and then investigated the effects on MRP1 expression, transport activity, and nucleotide and substrate interactions. A triple mutant in which Glu(1169), Glu(1170), and Glu(1172) were all replaced with Ala was also examined. The properties of R1173A and E1184A were comparable with those of wild-type MRP1, whereas the remaining mutants were either poorly expressed (R1166A, D1183A) or exhibited reduced transport of one or more organic anions (E1144A, D1179A, K1181A, (1169)AAQA). Same charge mutant D1183E was also not expressed, whereas expression and activity of R1166K were similar to wild-type MRP1. The moderate substrate-selective changes in transport activity displayed by mutants E1144A, D1179A, K1181A, and (1169)AAQA were accompanied by changes in orthovanadate-induced trapping of [alpha-(32)P]azidoADP by NBS2 indicating changes in ATP hydrolysis or release of ADP. In the case of E1144A, estradiol glucuronide no longer inhibited trapping of azidoADP. Together, our results demonstrate the extreme sensitivity of CL7 to mutation, consistent with its critical and complex dual role in both the proper folding and transport activity of MRP1.